why choose us

First received: September 16, 2022

Clinical Trial: Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing

Study Status: Completed

Recruit Status: RECRUITING

Condition: Opioid Use Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Trial to Evaluate Target Occupancy of CVL-354 at Kappa Opioid and Mu Opioid Receptors in Brain Following Single Oral Doses in Healthy Participants Using Positron Emission Tomogra

Brief Summary: The primary purpose of this study is to assess the target occupancy at kappa and mu opioid receptors in the brain after single oral doses of CVL-354 in healthy adult participants.

Read more